ALSPW Spineway SAS

Spineway : a week dedicated to medical excellence with more than 20 surgeons trained

Spineway : a week dedicated to medical excellence with more than 20 surgeons trained

Press release        

Ecully, November 14, 2024 – 6 p.m.

Spineway: a week dedicated to medical excellence with more than 20 surgeons trained

The Spineway Group, a , specialist in innovative implants for the treatment of severe spine disorders, organized a week of training dedicated to medical education from November 4 to 8, 2024. Through practical sessions in the operating room and on anatomical specimens in the laboratory, this intensive program trained over 20 international surgeons in the use of the Group’s ESP cervical and lumbar prostheses. These events also enabled the Group's distributors to provide ongoing training and support for their users.

           

The week began with a Costa Rican surgeon being trained in the operating room by Pr. Lazennec (Hôpital de la Pitié-Salpêtrière, AP-HP Paris) on cervical prosthesis (CP-ESP) and lumbar prosthesis (LP-ESP).

This was followed by a training session with two Indonesian surgeons led by Pr. Rousseau (Hôpital Bichat-Beaujon – AP-HP Paris), who focused on the LP-ESP lumbar prosthesis. At the end of the day, Mexican and Costa Rican practitioners had the opportunity to discuss their experiences with disc prostheses with Dr. Thierry Marnay during a round table in Nîmes.

The Mexican practitioners continued their training by participating in several procedures with the LP-ESP lumbar disc prosthesis. These sessions were led by Dr. Guillaume Gras-Combe (CHU de Nîmes-Pôle Neurosciences) and Dr. Jean-Patrick Rakover (Clinique du Pré, Le Mans).

The week ended with a training session on anatomical specimens at IRCAD Strasbourg for all the practitioners trained in the operating room during the week. They were joined by five Spanish and three Portuguese surgeons. Led by the experts Pr. Rousseau, Dr. Gras-Combe, Dr. Javier Giner (Instituto Clavel, Madrid) and Dr. Eduardo Espinosa (Neurocirugía Barcelona), the training included theoretical and practical sessions covering the characteristics, indications and surgical approaches for the placement of ESP disc prostheses.

Spineway’s teams, including Yiyi Li (MEA & Asia-Pacific Sales Manager), Lorenzo Tamas (Latin American Sales Manager), Inès Khaoua (Europe Sales Manager), Mélody Ourdouillié (Medical Education Events Manager) and Loïc Aden (ESP Product Manager), were on hand to provide optimal support.

These exchanges between surgeons illustrate Spineway’s commitment to supporting health professionals in their training, ensuring mastery of advanced technologies in the field of spinal implants and supporting the development of its international network. Spineway thus confirms its aim of becoming a major player in less invasive spine treatments in Europe, Latin America and Asia.

Next events:

December 5, 2024 – 6 p.m. CET – Webinar – Business update

January 22, 2025 – Full-year 2024 revenue

SPINEWAY IS ELIGIBLE FOR PEA-SME (EQUITY SAVINGS PLANS FOR SMES)

Find out all about Spineway at

This press release has been prepared in both English and French. In case of discrepancies, the French version shall prevail.

Spineway designs, manufactures and markets innovative implants and surgical instruments for treating severe disorders of the spinal column.

Spineway has an international network of independent distributors and derives more than 70% of its revenue from exports.

ISIN: FR001400BVK2 – ALSPW        

Contacts:





SPINEWAY



Shareholder-services line



Available Tuesday through Thursday



+33 (0)806 706 060
 



AELIUM



Investor relations



Solène Kennis







Attachment



EN
14/11/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Spineway SAS

 PRESS RELEASE

Spineway : H1 2025 results - Continued improvement in results and fina...

Spineway : H1 2025 results - Continued improvement in results and financial position Press release         Ecully, July 30, 2025 – 7 p.m.   SPINEWAY H1 2025 results  Continued improvement in results and financial positionFull-year 2025 growth target confirmed In thousands of eurosConsolidated financial statements – UnauditedH1 2025H1 2024Revenue5,5736,535Cost of sales(1,702)(2,059)Gross margin% of revenue3,87069%4,47668%Net operating expensesOf which general operating costs(5,068)(2,086)(5,246)(2,232)Of which personnel expenses(2,374)(2,685)Operating income/(loss)(1,197)(770)Fina...

 PRESS RELEASE

SPINEWAY : Résultats semestriels 2025 - Poursuite de l’amélioration de...

SPINEWAY : Résultats semestriels 2025 - Poursuite de l’amélioration des résultats et de la situation financière Communiqué de presse        Ecully, le 30 juillet 2025 –19h SPINEWAY Résultats semestriels 2025 Poursuite de l’amélioration des résultats et de la situation financièreObjectif de croissance confirmé pour l’année 2025 En milliers d'eurosComptes consolidés – Non auditésS1 2025S1 2024Chiffre d'affaires5 5736 535Coût des ventes- 1 702- 2 059Marge brute% du CA3 87069%4 47668%Coûts nets d’exploitationDont coûts de fonctionnement- 5 068- 2 086- 5 246- 2 232Dont charges de personnel-...

 PRESS RELEASE

Spineway : GMED approval for new production line dedicated to ESP pros...

Spineway : GMED approval for new production line dedicated to ESP prostheses - First production of LP-ESP intervertebral disc prostheses Press release         Ecully, July 3, 2025 – 6:30 p.m. SPINEWAY GMED approval for new production line dedicated to ESP prostheses First production of LP-ESP intervertebral disc prostheses Spineway, a specialist in innovative implants for the treatment of severe spine disorders, announces that its subsidiary Spine Innovations has received (French notified body) approval for its new production line dedicated to its LP-ESP and CP-ESP intervertebral di...

 PRESS RELEASE

SPINEWAY : Approbation du GMED pour la nouvelle ligne de production dé...

SPINEWAY : Approbation du GMED pour la nouvelle ligne de production dédiée aux prothèses ESP - 1ère production de prothèses de disque intervertébral LP-ESP Communiqué de presse          Ecully, le 3 juillet 2025 – 18h30 SPINEWAY Approbation du GMED pour la nouvelle ligne de production dédiée aux prothèses ESP 1ère production de prothèses de disque intervertébral LP-ESP Spineway, spécialiste des implants innovants pour le traitement des pathologies sévères de la colonne vertébrale (rachis), annonce que sa filiale Spine Innovations a reçu la validation du (Organisme notifié français) ...

 PRESS RELEASE

Spineway : Minutes of the General Meeting of June 4, 2025

Spineway : Minutes of the General Meeting of June 4, 2025 Press release         Ecully, June 6, 2025 – 6.00 p.m.   SPINEWAY Minutes of the General Meeting of June 4, 2025 The Combined General Meeting (Ordinary and Extraordinary) of Spineway shareholders was held on first notice on Wednesday, June 4, 2025 at 2:00 p.m at the company’s registered office, 7 allée Moulin Berger in Ecully (69). The defaulting shareholders were represented by SELARL TULIER POLGE ALIREZAI, as ad hoc representative appointed by Order of the President of the Lyon Commercial Court dated April 30, 2025. The...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch